Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma
Clinical trial NCT04842877 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04842877
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2024-12-03
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.